+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

RON (Recepteur d'origine Nantais) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

RON (Recepteur d'origine Nantais) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Transforming growth factor beta inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Transforming growth factor beta inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 150 Pages
  • Global
From
CD 33 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CD 33 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Tie-2 modulators - Pipeline Insight, 2024 - Product Thumbnail Image

Tie-2 modulators - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Vascular Endothelial Growth Factor Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Vascular Endothelial Growth Factor Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
TRAIL Receptor 1 & Receptor 2 Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

TRAIL Receptor 1 & Receptor 2 Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
B-Cell Activating Factor (BAFF) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

B-Cell Activating Factor (BAFF) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
4-1BB receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

4-1BB receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 100 Pages
  • Global
From
From
Beta-1 Receptors Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Beta-1 Receptors Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
GM-CSF Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

GM-CSF Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Tie-2 Receptor Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Tie-2 Receptor Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Ephrin (EPH) Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Ephrin (EPH) Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
CD 40 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CD 40 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Hypoxia Inducible Factor 1 (HIF-1) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Hypoxia Inducible Factor 1 (HIF-1) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Hedgehog Signaling Pathway Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Hedgehog Signaling Pathway Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Vascular endothelial growth factor A inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Vascular endothelial growth factor A inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more